Rx Drug Access Partnership
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 432,614 | 356,776 | 75,838 | 16.5 | 56% |
| 2013 | 361,036 | 372,785 | −11,749 | 15.4 | 60% |
| 2014 | 545,089 | 372,585 | 172,504 | 21.0 | 30% |
| 2015 | 412,526 | 392,693 | 19,833 | 20.5 | 63% |
| 2016 | 394,560 | 381,995 | 12,565 | 21.5 | 57% |
| 2017 | 589,692 | 434,734 | 154,958 | 23.1 | 22% |
| 2018 | 518,455 | 523,266 | −4,811 | 19.1 | 56% |
| 2019 | 605,677 | 557,686 | 47,991 | 19.0 | 56% |
| 2020 | 665,478 | 573,771 | 91,707 | 20.7 | 51% |
| 2021 | 727,629 | 614,832 | 112,797 | 23.1 | 54% |
| 2022 | 708,293 | 671,456 | 36,837 | 20.1 | 53% |
| 2023 | 746,153 | 694,909 | 51,244 | 21.4 | 44% |
| 2024 | 845,043 | 803,294 | 41,749 | 21.1 | 43% |
In its most recent public year (2024), this organization brought in $41,749 more than it spent. Its reserves stood at about 21.1 months of spending, up from 16.5 in 2012. Staff pay was 43% of spending. $145,000 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2024. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Rx Drug Access Partnership's IRS filings as a feed — one entry per filing year, through 2024. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works